Research and Markets (http://www.researchandmarkets.com/research/3q6n79/chronic_back) has announced the addition of the "Chronic Back Pain-Pipeline Insights" subscription to their offering.
This Chronic Back Pain-Pipeline Insights, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Chronic Back Pain.
This report provides information on the therapeutic development based on the Chronic Back Pain dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Chronic Back Pain Overview
- Chronic Back Pain Pipeline Therapeutics
- Chronic Back Pain Therapeutics under Development by Companies
- Chronic Back Pain Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Chronic Back Pain Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Chronic Back Pain Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Chronic Back Pain Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Chronic Back Pain - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Chronic Back Pain - Discontinued Products
- Chronic Back Pain - Dormant Products
- Companies Involved in Therapeutics Development for Chronic Back Pain
- Appendix
For more information visit http://www.researchandmarkets.com/research/3q6n79/chronic_back